The Clinical Efficacy of Pulmonary Hypertension-Specific Agents in Idiopathic Pulmonary Fibrosis: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
Jong Hoo LeeJae Uk SongPublished in: Journal of Korean medical science (2020)
Although PH-specific agents provided small health-related quality-of-life benefits, our meta-analysis provides insufficient evidence to support their use in IPF patients.
Keyphrases
- idiopathic pulmonary fibrosis
- pulmonary hypertension
- clinical trial
- systematic review
- end stage renal disease
- ejection fraction
- interstitial lung disease
- newly diagnosed
- open label
- double blind
- peritoneal dialysis
- prognostic factors
- meta analyses
- randomized controlled trial
- pulmonary artery
- rheumatoid arthritis
- patient reported outcomes
- study protocol